References
- Overdependence on drug importation, others kill local pharma industry, threaten medicine security. M.guardian.ng. 2020. https://m.guardian.ng/features/overdependence-on-drug-importation-others-kill-local-pharma-industry-threaten-medicine-security/amp/. Accessed 14 Dec 2020.
- How local manufacturing can reduce fake, substandard drugs in Nigeria. M.guardian.ng. 2020. https://m.guardian.ng/features/how-local-manufacturing-can-reduce-fake-substandard-drugs-in-nigeria/amp/. Accessed 14 Dec 2020.
- Dada DA, Aku E, David KB. COVID-19 pandemic and antiretrovirals (ARV) availability in Nigeria: recommendations to prevent shortages. Pan Afr Med J. 2020;35(Suppl 2):149.
- Akinyemi K, Fakorede C, Anjorin A, Abegunrin R, Adunmo O, Ajoseh S, et al. Intrigues and challenges associated with COVID-19 pandemic in Nigeria. Health. 2020;12(08):954–971.
- Nigeria: Averting Drug Scarcity in Nigeria. allAfrica.com. 2020. https://allafrica.com/stories/202004070630.html. Accessed 14 Dec 2020.
- Erah P, Bafor E. Assessment of pharmacist–patient communication in some health care facilities in Southern Nigeria. Niger J Pharm Res. 2005. https://doi.org/10.4314/njpr.v3i1.35380.
- Lucero-Prisno DE, Yusuff AA, Xu L. Current efforts and challenges facing responses to 2019-nCoV in Africa. Glob Health Res Policy. 2020. https://doi.org/10.1186/s41256-020-00148-1.
- Akande-Sholabi W, Adebisi Y. The impact of COVID-19 pandemic on medicine security in Africa: Nigeria as a case study. Pan Afr Med J. 2020. https://doi.org/10.11604/pamj.supp.2020.35.2.23671.
- Lucero-Prisno D, Elhadi Y, Modber M, Musa M, Mohammed S, Hassan K, et al. Drug shortage crisis in Sudan in times of COVID-19. Public Health Pract. 2020;1:100060.
- Nigeria relies heavily on drug imports. Why this is worrying in the time of COVID-19. The Conversation. 2020. https://www.google.com/amp/s/theconversation.com/amp/nigeria-relies-heavily-on-drug-imports-why-this-is-worrying-in-the-time-of-covid-19-134562. Accessed 14 Dec 2020.
- Collaboration O, Newton PN, Bond KC, Babar Z. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. Lancet Glob Health. 2020;8(6):e754–755. http://doi.org/10.1016/S2214-109X(20)30136-4.